Liver biopsy in living donors

Liver Transplantation

Volumn 8, Issue 12, 2002, Pages 1123-1125

  Rinella, Mary E ^a   Abecassis, Michael M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; LIPOFUSCIN; ORAL CONTRACEPTIVE AGENT;

ADULT; BLEEDING; BODY MASS; BODY WEIGHT; CHRONIC HEPATITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; EDITORIAL; FATTY LIVER; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER HEMATOMA; LIVER TRANSPLANTATION; LIVING DONOR; MORTALITY; OBESITY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RECIPIENT; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SAFETY; SCREENING TEST; TREATMENT OUTCOME; VEIN THROMBOSIS; BIOPSY; LIVER; NOTE; PATHOLOGY; PHYSIOLOGY;

ADULT; BIOPSY; HUMANS; LIVER; LIVER TRANSPLANTATION; LIVING DONORS; TREATMENT OUTCOME;

EID: 0036911219     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2002.36739     Document Type: Article

References (13)

1. Ryan CK, Johnson LA, Germin BI, Marcos A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002;8:1114-1122.
2. Piccinino, F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986;2:165-173.
3. Pasha T, Gabriel S, Therneau T, Dickson ER, Lindor KD. Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology 1998;27:1220-1226.
4. Minuk GY, Sutherland LR, Wiseman DA, MacDonald FR, Ding DL. Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bed rest after percutaneous liver biopsy. Gastroenterology 1987;92:290-293.
5. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292-298.
6. Casavilla A, Mazariegos G, Fung JJ. Cadaveric liver donors; what are the limits? Transplant Proc 1996;28:21-23.
7. Rinella ME, Alonso E, Rao S, Fryer J, Abecassis M, Superina R, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 2001;7:409-414.
8. Kaplan MM. Alanine aminotransferase levels: What's normal? Ann Intern Med 2002;137:49-51.
9. Beavers KL, Semelka RC. MRI evaluation of the liver. Semin Liver Dis 2001;21:161-177.
10. Rinella ME, McCarthy MR, Thakrar K, Rao S, Okolo P, Koffron AM, et al. Quantitative MRI assessment of hepatic steatosis in living donors may predict grade of steatosis on biopsy. Hepatology 2001;34(pt 2):343A.
11. Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: Disruption at two different levels in the regeneration pathway. Hepatology 2000;31:35-42.
12. Durand F, Ettorre GM, Douard R, Denninger MH, Kianmanesh A, Sommacale D, et al. Donor safety in living related liver transplantation: underestimation of the risks for deep vein thrombosis and pulmonary embolism. Liver Transpl 2002;8:118-120.
13. Haberal M, Telatar H, Demirag A, Boyacioglu S, Bilgin N. Is needle biopsy mandatory for donor selection in live donor segmental liver transplantation? Transplant Proc 1995;27:2605-2606.